Trials / Completed
CompletedNCT00213798
Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients
Detection of Plasma DNA by Allelotyping in Non Small Cell and Small Cell Lung Cancer Patients. Evolution During Treatment and Follow-up.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The majority of lung cancer patients have a tumor-derived genetic alteration in circulating plasma DNA that could be exploited as a diagnostic tool. The aim of this study is to evaluate if plasma DNA can be used as a valuable non invasive test to monitor disease progression without assessing the tumor.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Biopsy samples |
Timeline
- Start date
- 2003-12-01
- Completion
- 2011-08-01
- First posted
- 2005-09-21
- Last updated
- 2025-12-22
Locations
4 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00213798. Inclusion in this directory is not an endorsement.